Estimation of the in-vivo minimum inhibitory concentration of cipargamin in uncomplicated Plasmodium falciparum malaria

Estimation of the in-vivo minimum inhibitory concentration of cipargamin in uncomplicated Plasmodium falciparum malaria

The minimum inhibitory concentration (MIC) of an antimalarial drug for a particular infection is the drug level associated with a net parasite multiplication rate of one per asexual cycle. To ensure cure of malaria the MIC must be exceeded until all parasites have been eliminated. The development of...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Tinh Tran, H, White, N, Thanh Nguyen, T, Toa Nhu, H, Duc Phung, T, Tarning, J, Nosten, F, Magnusson, B, Prakash Jain, J, Hamed, K
Μορφή:	Journal article
Έκδοση:	American Society for Microbiology 2016

Παρόμοια τεκμήρια

Assessment in vitro of the antimalarial and transmission-blocking activities of cipargamin and ganaplacide in artemisinin-resistant Plasmodium falciparum
ανά: Yipsirimetee, A, κ.ά.
Έκδοση: (2022)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin
ανά: Deyun Qiu, κ.ά.
Έκδοση: (2022-09-01)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2014)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2013)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
ανά: Tarning, J, κ.ά.
Έκδοση: (2013)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Uganda
ανά: Tarning Joel, κ.ά.
Έκδοση: (2012-08-01)

Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa
ανά: Gilles Ndayisaba, κ.ά.
Έκδοση: (2021-12-01)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2009)

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria
ανά: James M. Colborn, κ.ά.
Έκδοση: (2015-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
ανά: Lwin, K, κ.ά.
Έκδοση: (2008)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
ανά: Hoglund Richard M, κ.ά.
Έκδοση: (2012-11-01)

Clinically uncomplicated <it>Plasmodium falciparum </it>malaria with high schizontaemia: A case report
ανά: Ashley Elizabeth A, κ.ά.
Έκδοση: (2008-04-01)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
ανά: Nosten, F
Έκδοση: (2010)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2015)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
ανά: Chiodini, P, κ.ά.
Έκδοση: (1995)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
ανά: Prakash Ghimire, κ.ά.
Έκδοση: (2018-08-01)

Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria
ανά: Das, J, κ.ά.
Έκδοση: (2018)

Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
ανά: Junjie Ding, κ.ά.
Έκδοση: (2024-11-01)

Fever in uncomplicated Plasmodium falciparum infection: effects of quinine and paracetamol.
ανά: Krishna, S, κ.ά.
Έκδοση: (1995)

A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.
ανά: Pattamawan Chimma, κ.ά.
Έκδοση: (2009-10-01)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
ανά: Ahmed Elderderi S, κ.ά.
Έκδοση: (2005-09-01)

A randomised controlled trial of 3 versus 5 days artemether-lumefantrine regimen for uncomplicated Plasmodium falciparum treatment in pregnancy in Africa
ανά: Onyamboko, M, κ.ά.
Έκδοση: (2019)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
ανά: Valea, I, κ.ά.
Έκδοση: (2014)

Artemisinin-based combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria in Colombia
ανά: Taylor Walter RJ, κ.ά.
Έκδοση: (2007-02-01)

Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya.
ανά: Shanks, G, κ.ά.
Έκδοση: (2005)

Efficacy and safety of dihydroartemisinin-piperaquine in Indonesian children infected with uncomplicated Plasmodium falciparum and Plasmodium vivax
ανά: Emiliana Tjitra, κ.ά.
Έκδοση: (2011-12-01)

Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
ανά: Luxemburger, C, κ.ά.
Έκδοση: (1995)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
ανά: Ashenafi Assefa, κ.ά.
Έκδοση: (2022-12-01)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2008)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

Optimising statistical methodologies for estimating antimalarial efficacy for uncomplicated Plasmodium falciparum malaria
ανά: Dahal, P
Έκδοση: (2018)

Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania
ανά: Billy Ngasala, κ.ά.
Έκδοση: (2024-03-01)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
ανά: Florian Kurth, κ.ά.
Έκδοση: (2016-08-01)